List of Chapters/Sections(Table Of Content)
1 Introduction to Research & Analysis Reports
1.1 AI-based Clinical Trials Solution Provider Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global AI-based Clinical Trials Solution Provider Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global AI-based Clinical Trials Solution Provider Overall Market Size
2.1 Global AI-based Clinical Trials Solution Provider Market Size: 2022 VS 2028
2.2 Global AI-based Clinical Trials Solution Provider Market Size, Prospects & Forecasts: 2022-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Key AI-based Clinical Trials Solution Provider Players in Global Market
3.2 Global Companies AI-based Clinical Trials Solution Provider Product & Technology
4 Players Profiles
4.1 Unlearn.AI, Inc.
4.1.1 Unlearn.AI, Inc. Corporate Summary
4.1.2 Unlearn.AI, Inc. Business Overview
4.1.3 Unlearn.AI, Inc. AI-based Clinical Trials Solution Provider Product Offerings & Technology
4.1.4 Unlearn.AI, Inc. AI-based Clinical Trials Solution Provider R&D, and Plans
4.2 Saama Technologies
4.2.1 Saama Technologies Corporate Summary
4.2.2 Saama Technologies Business Overview
4.2.3 Saama Technologies AI-based Clinical Trials Solution Provider Product Offerings & Technology
4.2.4 Saama Technologies AI-based Clinical Trials Solution Provider R&D, and Plans
4.3 Antidote Technologies, Inc.
4.3.1 Antidote Technologies, Inc. Corporate Summary
4.3.2 Antidote Technologies, Inc. Business Overview
4.3.3 Antidote Technologies, Inc. AI-based Clinical Trials Solution Provider Product Offerings & Technology
4.3.4 Antidote Technologies, Inc. AI-based Clinical Trials Solution Provider R&D, and Plans
4.4 Phesi
4.4.1 Phesi Corporate Summary
4.4.2 Phesi Business Overview
4.4.3 Phesi AI-based Clinical Trials Solution Provider Product Offerings & Technology
4.4.4 Phesi AI-based Clinical Trials Solution Provider R&D, and Plans
4.5 Deep 6 AI
4.5.1 Deep 6 AI Corporate Summary
4.5.2 Deep 6 AI Business Overview
4.5.3 Deep 6 AI AI-based Clinical Trials Solution Provider Product Offerings & Technology
4.5.4 Deep 6 AI AI-based Clinical Trials Solution Provider R&D, and Plans
4.6 Innoplexus
4.6.1 Innoplexus Corporate Summary
4.6.2 Innoplexus Business Overview
4.6.3 Innoplexus AI-based Clinical Trials Solution Provider Product Offerings & Technology
4.6.4 Innoplexus AI-based Clinical Trials Solution Provider R&D, and Plans
4.7 Mendel.ai
4.7.1 Mendel.ai Corporate Summary
4.7.2 Mendel.ai Business Overview
4.7.3 Mendel.ai AI-based Clinical Trials Solution Provider Product Offerings & Technology
4.7.4 Mendel.ai AI-based Clinical Trials Solution Provider R&D, and Plans
4.8 Intelligencia
4.8.1 Intelligencia Corporate Summary
4.8.2 Intelligencia Business Overview
4.8.3 Intelligencia AI-based Clinical Trials Solution Provider Product Offerings & Technology
4.8.4 Intelligencia AI-based Clinical Trials Solution Provider R&D, and Plans
4.9 Median Technologies
4.9.1 Median Technologies Corporate Summary
4.9.2 Median Technologies Business Overview
4.9.3 Median Technologies AI-based Clinical Trials Solution Provider Product Offerings & Technology
4.9.4 Median Technologies AI-based Clinical Trials Solution Provider R&D, and Plans
4.10 Symphony AI
4.10.1 Symphony AI Corporate Summary
4.10.2 Symphony AI Business Overview
4.10.3 Symphony AI AI-based Clinical Trials Solution Provider Product Offerings & Technology
4.10.4 Symphony AI AI-based Clinical Trials Solution Provider R&D, and Plans
4.11 BioAge Labs, Inc.
4.11.1 BioAge Labs, Inc. Corporate Summary
4.11.2 BioAge Labs, Inc. Business Overview
4.11.3 BioAge Labs, Inc. AI-based Clinical Trials Solution Provider Product Offerings & Technology
4.11.4 BioAge Labs, Inc. AI-based Clinical Trials Solution Provider R&D, and Plans
4.12 AiCure, LLC
4.12.1 AiCure, LLC Corporate Summary
4.12.2 AiCure, LLC Business Overview
4.12.3 AiCure, LLC AI-based Clinical Trials Solution Provider Product Offerings & Technology
4.12.4 AiCure, LLC AI-based Clinical Trials Solution Provider R&D, and Plans
4.13 CONSILX
4.13.1 CONSILX Corporate Summary
4.13.2 CONSILX Business Overview
4.13.3 CONSILX AI-based Clinical Trials Solution Provider Product Offerings & Technology
4.13.4 CONSILX AI-based Clinical Trials Solution Provider R&D, and Plans
4.14 DEEP LENS AI
4.14.1 DEEP LENS AI Corporate Summary
4.14.2 DEEP LENS AI Business Overview
4.14.3 DEEP LENS AI AI-based Clinical Trials Solution Provider Product Offerings & Technology
4.14.4 DEEP LENS AI AI-based Clinical Trials Solution Provider R&D, and Plans
4.15 Halo Health Systems
4.15.1 Halo Health Systems Corporate Summary
4.15.2 Halo Health Systems Business Overview
4.15.3 Halo Health Systems AI-based Clinical Trials Solution Provider Product Offerings & Technology
4.15.4 Halo Health Systems AI-based Clinical Trials Solution Provider R&D, and Plans
4.16 Pharmaseal
4.16.1 Pharmaseal Corporate Summary
4.16.2 Pharmaseal Business Overview
4.16.3 Pharmaseal AI-based Clinical Trials Solution Provider Product Offerings & Technology
4.16.4 Pharmaseal AI-based Clinical Trials Solution Provider R&D, and Plans
4.17 Ardigen
4.17.1 Ardigen Corporate Summary
4.17.2 Ardigen Business Overview
4.17.3 Ardigen AI-based Clinical Trials Solution Provider Product Offerings & Technology
4.17.4 Ardigen AI-based Clinical Trials Solution Provider R&D, and Plans
4.18 Trials.Ai
4.18.1 Trials.Ai Corporate Summary
4.18.2 Trials.Ai Business Overview
4.18.3 Trials.Ai AI-based Clinical Trials Solution Provider Product Offerings & Technology
4.18.4 Trials.Ai AI-based Clinical Trials Solution Provider R&D, and Plans
4.19 Koneksa Health
4.19.1 Koneksa Health Corporate Summary
4.19.2 Koneksa Health Business Overview
4.19.3 Koneksa Health AI-based Clinical Trials Solution Provider Product Offerings & Technology
4.19.4 Koneksa Health AI-based Clinical Trials Solution Provider R&D, and Plans
4.20 Euretos
4.20.1 Euretos Corporate Summary
4.20.2 Euretos Business Overview
4.20.3 Euretos AI-based Clinical Trials Solution Provider Product Offerings & Technology
4.20.4 Euretos AI-based Clinical Trials Solution Provider R&D, and Plans
4.21 BioSymetrics
4.21.1 BioSymetrics Corporate Summary
4.21.2 BioSymetrics Business Overview
4.21.3 BioSymetrics AI-based Clinical Trials Solution Provider Product Offerings & Technology
4.21.4 BioSymetrics AI-based Clinical Trials Solution Provider R&D, and Plans
4.22 Google- Verily
4.22.1 Google- Verily Corporate Summary
4.22.2 Google- Verily Business Overview
4.22.3 Google- Verily AI-based Clinical Trials Solution Provider Product Offerings & Technology
4.22.4 Google- Verily AI-based Clinical Trials Solution Provider R&D, and Plans
4.23 GNS Healthcare
4.23.1 GNS Healthcare Corporate Summary
4.23.2 GNS Healthcare Business Overview
4.23.3 GNS Healthcare AI-based Clinical Trials Solution Provider Product Offerings & Technology
4.23.4 GNS Healthcare AI-based Clinical Trials Solution Provider R&D, and Plans
4.24 IBM Watson
4.24.1 IBM Watson Corporate Summary
4.24.2 IBM Watson Business Overview
4.24.3 IBM Watson AI-based Clinical Trials Solution Provider Product Offerings & Technology
4.24.4 IBM Watson AI-based Clinical Trials Solution Provider R&D, and Plans
4.25 Exscientia
4.25.1 Exscientia Corporate Summary
4.25.2 Exscientia Business Overview
4.25.3 Exscientia AI-based Clinical Trials Solution Provider Product Offerings & Technology
4.25.4 Exscientia AI-based Clinical Trials Solution Provider R&D, and Plans
5 Sights by Region
5.1 By Region - Global AI-based Clinical Trials Solution Provider Market Size, 2023 & 2028
5.2 By Region - Global AI-based Clinical Trials Solution Provider Revenue, (2023-2028)
5.3 United States
5.3.1 Key Players of AI-based Clinical Trials Solution Provider in United States
5.3.2 United States AI-based Clinical Trials Solution Provider Development Current Situation and Forecast
5.4 Europe
5.4.1 Key Players of AI-based Clinical Trials Solution Provider in Europe
5.4.2 Europe AI-based Clinical Trials Solution Provider Development Current Situation and Forecast
5.5 China
5.5.1 Key Players of AI-based Clinical Trials Solution Provider in China
5.5.2 China AI-based Clinical Trials Solution Provider Development Current Situation and Forecast
5.6 Rest of World
6 Sights by Product
6.1 by Type - Global AI-based Clinical Trials Solution Provider Market Size Markets, 2023 & 2028
6.2 Phase-I
6.3 Phase-II
6.4 Phase-III
7 Sights by Application
7.1 By Application - Global AI-based Clinical Trials Solution Provider Market Size, 2023 & 2028
7.2 Pharmaceutical Companies
7.3 Academia
7.4 Others
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
